FABP1 and metabolic dysfunction-associated steatotic liver disease: Atshaves et al10 emphasized the role of LFABP in obesity, but in the literature, there is insufficient data on LFABP levels in lean vs. obese NAFLD patients, and in obese patients with or without NAFLD, studies are needed to provide more accurate insights into these topics.